Secondary revascularisation following intracoronary brachytherapy

EuroIntervention

Volumn 5, Issue SUPPL. D, 2009, Pages

  Sabaté, Manel ^a  

^a University Hospital Sant Pau   (Spain)

Author keywords

Edge; Effect; In stent restenosis; Intracoronary brachytherapy; Late thrombosis; Secondary coronary revascularisation

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; RAPAMYCIN; TICLOPIDINE;

BARE METAL STENT; BRACHYTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DRUG ELUTING STENT; GAMMA RADIATION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; PERCUTANEOUS CORONARY INTERVENTION; RECURRENT DISEASE; RESTENOSIS; REVIEW; STENT THROMBOSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BRACHYTHERAPY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; METALS; PROSTHESIS DESIGN; RECURRENCE; STENTS; THROMBOSIS; TREATMENT FAILURE;

EID: 77953682319     PISSN: 1774024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Kovalic JJ, Perez CA. Radiation therapy following keloidectomy: a 20-year experience. Int J Radiat Oncol Biol Phys. 1989;17:77-80.
2. Walter WL, Another look at pterygium surgery with postoperative beta radiation. Ophthal Plast Reconst Surg. 1994;10:247-252.
3. Friedman M, Felton L, Byers S. The antiatherogenic effect of iridium192 upon the cholesterol-fed rabbit. J Clin Invest. 1964;43:185-192.
4. Liermann D, Bottcher HD, Kollath J, Schopohl B, Strassmann G, Strecker EP, Breedin KH. Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries. Cardiovasc Intervent Radiol. 1994;17:12-16.
5. Wiedermann JG, Marboe C, Amols H, Schwartz A, Weinberger J. Intracoronary irradiation markedly reduces neointimal proliferation after balloon angioplasty in swine: persistent benefit at 6-month follow-up. J Am Coll Cardiol. 1995;25:1451-1456.
6. Waksman R, Robinson KA, Crocker IR, Wang C, Gravanis MB, Cipolla GD, Hillstead RA, King SB, 3rd. Intracoronary low-dose beta-irradiation inhibits neointima formation after coronary artery balloon injury in the swine restenosis model. Circulation. 1995;92:3025-3031.
7. Mazur W, Alin MN, Dabaghi SF, DeFelice CA, Paradis P, Jr., Butler EB, Wright AE, Fajardo LF, French BA, Raizner AE. High dose rate intracoronary radiation for inhibition of neointimal formation in the stented and balloon-injured porcine models of restenosis: angiographic, morphometric, and histopathologic analyses. Int J Radiat Oncol Biol Phys. 1996;36:777-788.
8. Verin V, Popowski Y, Urban P, Belenger J, Redard M, Costa M, Widmer MC, Rouzaud M, Nouet P, Grob E. Intraarterial bete-irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model. Circulation. 1995;92:2284-2290.
9. Condado JA, Waksman R, Gurdiel O, Espinosa R, Gonzalez J, Burger B, Villoria G, Acquatella H, Crocker IR, Seung KB, Liprie SF. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation. 1997;96:727-732.
10. Verin V, Urban P, Popowski Y, Schwager M, Nouet P, Dorsaz PA, Chatelain P, Kurtz JM, Rutishauser W. Feasibility of intracoronory beta-irradiation to reduce restenosis after balloon angioplasty. A clinical pilot study. Circulation. 1997;95:1138-1144.
11. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Morris NB, Leon MB, Tripuraneni P. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 1997;336:1697-1703.
12. Waksman R, Vascular brachytherapy. 2nd ed, New York: Futura Publishing Company; 1999.
13. Teirstein PS, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Sirkin K, Cloutier DA, Leon MB, Tripuraneni P. Three-year clinical and angiographic follow-up after intracoronary radiation. Results of a randomized clinical trials. Circulation. 2000;101:360-365.
14. Waksman R, White L, Chan R, Bass BG, Geirlach L, Mintz GS, Satler LF, Mehran R, Serruys PW, Lansky AJ, Fitzgerald P, Bhargava B, Kent KM, Pichard AD, Leon MB. Intracoronary gamma-radiation therapy after angioplasty inhibit recurrence in patients with in-stent restenosis. Circulation 2000;101:2165-2171.
15. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, Wong SC, Fish D, Ellis S, Holmes DR, Kerieakes D, Kuntz RE. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344:250-256.
16. Waksman R, Cheneau E, Ajani AE, White RL, Pinnow E, Torguson R, Deible R, Satler LF, Pichard AD, Kent KM, Teirstein PS, Lindsay J; Washington Radiation for In-Stent Restenosis Trial for Long Lesions Studies. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies. Circulation. 2003 Apr 8;107:(13):1744-9
17. Waksman R, Bhargava B, White LR, Chan RC, Mehran R, Lansky AJ, Mintz GS, Satler LF, Pichard AD, Leon MB, Kent KK. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation 2000;101:1895-1898.
18. Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, Massullo V, Bass T, Henderson R, Silber S, von, Rottkay P, Bonan R, Ho KK, Osattin A, Kuntz RE; Stents And Radiation Therapy (START) Investigators. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation. 2002 Aug 27;106(9):1090-6.
19. Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localised intracoronary beta-radiation in treatment of in-stent restenosis: The INHIBIT randomised controlled trial. Lancet 2002;359:551-557.
20. Silber S, Albertson P, Avilés FF, Camici PG, Colombo A, Hamm C, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W; Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005 Apr;26(8):804-47.
21. Serruys PW, Wijns W, Sianos G, de Scheerder I, van den Heuvel PA, Rutsch W, Glogar HD, Macaya C, Materne PH, Veldhof S, Vonhausen H, Otto-Terlouw PC, van der Giessen WJ. Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial: Beta-Radiation Investigation with Direct Stenting and Galileo in Europe (Bridge). J Am Coll Cardiol. 2004 Aug 4;44(3):528-37.
22. Sabaté M, Pimentel G, Prieto C, Corral JM, Bañuelos C, Angiolillo DJ, Alfonso F, Hernández-Antolín R, Escaned J, Fantidis P, Fernández C, Fernández-Ortiz A, Moreno R, Macaya C. Intracoronary brachytherapy after stenting de novo lesions in diabetic patients: results of a randomized intravascular ultrasound study. J Am Coll Cardiol. 2004 Aug 4;44(3):520-7.
23. Albiero R, Adamian M, Kobayashi N, Amato A, Vaghetti M, Di Mario C, Colombo A. Short- and intermediate-term results of P32radioactive β-emitting stent implantation in patients with coronary artery disease. The Milan dose-response study. Circulation. 2000; 101:18-26.
24. Sabaté M, Serruys PW, van der Gieseen WJ, Ligthart JM, Coen VL, Kay IP, Gijzel AL, Wardeh AJ, den Boer A, Lavendag PC. Geometric vascular remodelling after balloon angioplasty and beta-radiation therapy: a three-dimensional intravascular ultrasound study. Circulation. 1999;100:1182-1188.
25. Sabaté M, Costa MA, Kozuma K, Kay IP, van der Giessen WJ, Coen VL, Ligthart JM, Serrano P, Levendag PC, Serruys PW. Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation. 2000, 101:2467-2471.
26. Kay IP, Sabaté M, Costa MA, Kozuma K, Alberta M, van der Giessen WJ, Wardeh AJ, Ligthart JM, Coen VM, Levendag PC, Serruys PW. Positive geometric vascular remodeling is seen after catheter-based radiation followed by conventional stent implantation, but not after radioactive stent implantation. Circulation. 2000, 102:1434-1439.
27. Kozuma K, Costa MA, Sabaté M, Kay IP, Marijinissen JP, Coen VL, Serrano P, Ligthart JM, Levendag PC, Serruys PW. Three-dimensional ultrasound assessment of non-injured edges of beta-irradiated coronary segments. Circulation 2000;102:1484-1489.
28. Kay IP, Wardeh AJ, Kozuma K, Sianos G, Regar E, Knook M, van der Giessen WJ, Thury A, Ligthart JM, Coen VM, Levendag PC, Serruys PW. The pattern of restenosis and vascular remodelling after cold-end radioactive stent implantation. Eur Heart J. 2001 Aug;22(15):1311-7.
29. Hall EJ, Miller RC, Brenner DJ. The basic radiobiology in intravascular irradiation. In: Waksman R (ed.). Vascular brachytherapy. Second Edition. Armonk, NY: Futura Publishing Co., Inc.;1999:63-72.
30. Ajani AE, Waksman R, Sharma AK, Cha DH, Cheneau E, White RL, Canos D, Pichard AD, Satler LF, Kent KM, Pinnow E, Lindsay J. Three-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Original WRIST. Washington Radiation for In-Stent Restenosis Trial. Cardiovasc Radiat Med. 2001;2:200-4.
31. Ferrero V, Ribichini F, Piessens M, Heyndrickx GR, Verbeke L, de Bruyne B, Feola M, Vassanelli C, Wijns W. Intracoronary beta-irradiation for the treatment of de novo lesions. 5-year clinical follow-up of the BetAce randomized trial. Am Heart J. 2007 Mar;153(3):398-402.
32. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676-1688.
33. Costa M, Sabaté M, van der Giessen WJ, Kay IP, Cervinka P, Ligthart JM, Serrano P, Coen VL, Levendag PC, Serruys PW. Late coronary occlusion after intracoronary brachytherapy. Circulation. 1999; 100:789-792.
34. Waksman R, Bhargava B, Mintz GS, Mehran R, Lansky AJ, Satler LF, Pichard AD, Kent KM, Leon MB. Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol 2000;36:65-68.
35. Farb A, Tang A, Virmani R. The neointima is reduced but endothelialization is incomplete 3 months after 32P β-emitting stent placement. Circulation. 1998;98(suppl 1):1-770. Abstract.
36. Sabaté M, van der Giessen WJ, Deshpande NV, Ligthart J, Kay I, Bruining N. Serruys PW. Late thrombotic occlusion of a malapposed stent 10 months after intracoronary brachytherapy. Int J Cardiovasc Interv. 1999;2:55-59.
37. Kay IP, Sabaté M, van Langenhove G. The outcome from balloon induced coronary artery dissection, after intracoronary β-radiation. Heart 2000;83:332-337.
38. Waksman R, Ajani AE, Pinnow E, Cheneau E, Leborgne L, Dieble R, Bui AB, Satler LF, Pichard AD, Kent KK, Lindsay J. Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS. Circulation 2002;106:776-778.
39. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, Russell ME; TAXUS V ISR Investigators. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA. 2006 Mar 15;295(11):1253-63.
40. Holmes DR Jr, Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, Kuntz RE, Fitzgerald PJ, Wang H, Caramanica E, Cohen SA; SISR Investigators. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA, 2006 Mar 15;295(11):1264-73.
41. Dibra A, Kastrati A, Alfonso F, Seyfarth M, Pérez-Vizcayno MJ, Mehilli J, Schömig A. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials. J Am Coll Cardiol. 2007 Feb 6;49(5):616-23.
42. Torguson R, Sabate M, Deible R, Smith K, Chu WW, Kent KM, Pichard AD, Suddath WO, Satler LF, Waksman R. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis. Am J Cardiol. 2006 Nov 15;98(10):1340-4.